• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉微血管功能障碍的当前观点

Current perspectives in coronary microvascular dysfunction.

作者信息

Shome Joy S, Perera Divaka, Plein Sven, Chiribiri Amedeo

机构信息

Division of Imaging Sciences and Biomedical Engineering, The Rayne Institute, King's College London, St. Thomas' Hospital, London, UK.

Cardiovascular Division, The Rayne Institute, King's College London, St. Thomas' Hospital, London, UK.

出版信息

Microcirculation. 2017 Jan;24(1). doi: 10.1111/micc.12340.

DOI:10.1111/micc.12340
PMID:27976459
Abstract

The coronary arterial system consists of large epicardial coronary arteries, pre-arterioles, and arterioles, which together closely regulate CBF. Structural, functional, and extravascular abnormalities of the microcirculation lead to CMD. CMD can present with symptoms suggestive of CAD, often in the absence of significant obstructive epicardial CAD. Conventional invasive angiography does not allow direct visualization of the microcirculation. Invasive indices, such as CBF and CFR, and non-invasive imaging modalities, such as CMR and PET, can be used to quantify absolute MBF and enable a direct and accurate assessment of coronary microvascular function. CMD appears to be more prevalent in women, typically presenting with symptoms of ischemia with unobstructed coronary arteries, and has a relatively unfavorable prognosis. CMD is classified clinically depending on the presence or absence of epicardial CAD, myocardial disease, or iatrogenic causes. Although invasive intracoronary techniques can be used to detect CMD, these cannot provide insight into the mechanisms involved in its pathogenesis. Imaging modalities such as CMR and cardiac PET are becoming indispensable tools in the evaluation of suspected CMD.

摘要

冠状动脉系统由大的心外膜冠状动脉、前小动脉和小动脉组成,它们共同紧密调节冠状动脉血流量(CBF)。微循环的结构、功能及血管外异常会导致冠状动脉微血管疾病(CMD)。CMD可能表现出提示冠心病(CAD)的症状,通常在不存在明显阻塞性心外膜CAD的情况下出现。传统的有创血管造影无法直接观察微循环。诸如CBF和冠状动脉血流储备(CFR)等有创指标,以及诸如心脏磁共振成像(CMR)和正电子发射断层扫描(PET)等无创成像方式,可用于量化绝对心肌血流量(MBF),并能直接准确地评估冠状动脉微血管功能。CMD在女性中似乎更为普遍,通常表现为冠状动脉通畅时的缺血症状,且预后相对较差。CMD根据是否存在心外膜CAD、心肌病或医源性病因进行临床分类。尽管有创冠状动脉内技术可用于检测CMD,但这些技术无法深入了解其发病机制中涉及的机制。诸如CMR和心脏PET等成像方式正成为评估疑似CMD时不可或缺的工具。

相似文献

1
Current perspectives in coronary microvascular dysfunction.冠状动脉微血管功能障碍的当前观点
Microcirculation. 2017 Jan;24(1). doi: 10.1111/micc.12340.
2
Intracoronary electrocardiogram detects coronary microvascular dysfunction and ischemia in patients with no obstructive coronary arteries disease.冠状动脉内心电图可检测无阻塞性冠状动脉疾病患者的冠状动脉微血管功能障碍和缺血情况。
Am Heart J. 2024 Apr;270:62-74. doi: 10.1016/j.ahj.2024.01.003. Epub 2024 Jan 25.
3
Elevated serum endothelin-1 is an independent predictor of coronary microvascular dysfunction in non-obstructive territories in patients with coronary artery disease.血清内皮素-1 水平升高是冠心病患者非阻塞性病变部位冠状动脉微血管功能障碍的独立预测因子。
Heart Vessels. 2021 Jul;36(7):917-923. doi: 10.1007/s00380-020-01767-x. Epub 2021 Jan 23.
4
Coronary microvascular disease: The "Meeting Point" of Cardiology, Rheumatology and Endocrinology.冠状动脉微血管疾病:心脏病学、风湿病学与内分泌学的“交汇点”
Eur J Clin Invest. 2022 May;52(5):e13737. doi: 10.1111/eci.13737. Epub 2022 Jan 4.
5
Invasive evaluation of coronary microvascular dysfunction.冠状动脉微血管功能障碍的有创评估。
J Nucl Cardiol. 2022 Oct;29(5):2474-2486. doi: 10.1007/s12350-022-02997-4. Epub 2022 May 26.
6
Coronary microvascular dysfunction by positron emission tomography and outcomes in patients after cardiac transplantation.心脏移植术后患者经正电子发射断层扫描检测的冠状动脉微血管功能障碍及其预后
Eur Heart J Cardiovasc Imaging. 2025 May 30;26(6):957-965. doi: 10.1093/ehjci/jeaf042.
7
Clinical implications of coronary microvascular dysfunction in patients with non-obstructive coronary artery disease and role of the thermodilution method.非阻塞性冠状动脉疾病患者冠状动脉微血管功能障碍的临床意义及热稀释法的作用。
Minerva Cardiol Angiol. 2025 Feb;73(1):23-37. doi: 10.23736/S2724-5683.23.06289-0. Epub 2023 Mar 20.
8
SPECT myocardial ischemia in the absence of obstructive CAD: Contribution of the invasive assessment of microvascular dysfunction.SPECT 心肌缺血而无阻塞性 CAD:微血管功能障碍的有创评估的贡献。
J Nucl Cardiol. 2018 Jun;25(3):1017-1022. doi: 10.1007/s12350-017-1135-1. Epub 2017 Dec 5.
9
Relationship between coronary microvascular dysfunction (CMD) and left ventricular diastolic function in patients with symptoms of myocardial ischemia with non-obstructive coronary artery disease (INOCA) by cardiovascular magnetic resonance feature-tracking.采用心血管磁共振特征追踪技术研究有心肌缺血症状但冠状动脉无阻塞性疾病(INOCA)患者的冠状动脉微血管功能障碍(CMD)与左心室舒张功能的关系。
Clin Radiol. 2024 Jul;79(7):536-543. doi: 10.1016/j.crad.2024.02.007. Epub 2024 Mar 13.
10
Coronary microvascular disease in women: epidemiology, mechanisms, evaluation, and treatment.女性冠状动脉微血管疾病:流行病学、机制、评估和治疗。
Can J Physiol Pharmacol. 2024 Oct 1;102(10):594-606. doi: 10.1139/cjpp-2023-0414. Epub 2024 May 10.

引用本文的文献

1
Coronary microvascular dysfunction: a review of its association with extracardiac organ pathologies.冠状动脉微血管功能障碍:其与心外器官病理状况相关性的综述
Front Cardiovasc Med. 2025 Aug 13;12:1616332. doi: 10.3389/fcvm.2025.1616332. eCollection 2025.
2
Retinal optical coherence tomography angiography (OCTA) biomarkers of cardiovascular disease: a review article.心血管疾病的视网膜光学相干断层扫描血管造影(OCTA)生物标志物:一篇综述文章。
Eye (Lond). 2025 May 14. doi: 10.1038/s41433-025-03780-8.
3
Understanding Diabetic Cardiomyopathy: Insulin Resistance and Beyond.
了解糖尿病性心肌病:胰岛素抵抗及其他因素
Heart Int. 2024 Dec 4;18(2):7-13. doi: 10.17925/HI.2024.18.2.2. eCollection 2024.
4
Female-Specific Considerations in Aortic Health and Disease.主动脉健康与疾病中的女性特定考量因素
CJC Open. 2023 Sep 15;6(2Part B):391-406. doi: 10.1016/j.cjco.2023.09.006. eCollection 2024 Feb.
5
BAY-6096: A Potent, Selective, and Highly Water-Soluble Adrenergic α Antagonist.BAY-6096:一种强效、选择性和高水溶性的肾上腺素能 α 拮抗剂。
J Med Chem. 2023 Apr 13;66(7):4659-4670. doi: 10.1021/acs.jmedchem.2c01690. Epub 2023 Mar 18.
6
Stress CMR T1-mapping technique for assessment of coronary microvascular dysfunction in a rabbit model of type II diabetes mellitus: Validation against histopathologic changes.应激心脏磁共振成像T1映射技术评估2型糖尿病兔模型冠状动脉微血管功能障碍:与组织病理学变化的对照验证
Front Cardiovasc Med. 2023 Jan 20;9:1066332. doi: 10.3389/fcvm.2022.1066332. eCollection 2022.
7
Assessment and Treatment for Coronary Microvascular Dysfunction by Contrast Enhanced Ultrasound.经造影增强超声评估与治疗冠状动脉微血管功能障碍
Front Cardiovasc Med. 2022 Jun 20;9:899099. doi: 10.3389/fcvm.2022.899099. eCollection 2022.
8
Plin5, a New Target in Diabetic Cardiomyopathy.Plin5,糖尿病性心肌病的新靶点。
Oxid Med Cell Longev. 2022 Apr 25;2022:2122856. doi: 10.1155/2022/2122856. eCollection 2022.
9
HuR/Cx40 downregulation causes coronary microvascular dysfunction in type 2 diabetes.HuR/Cx40 下调导致 2 型糖尿病患者的冠状动脉微血管功能障碍。
JCI Insight. 2021 Nov 8;6(21):e147982. doi: 10.1172/jci.insight.147982.
10
Adeno-associated viral (AAV) vector-mediated therapeutics for diabetic cardiomyopathy - current and future perspectives.腺相关病毒(AAV)载体介导的糖尿病心肌病治疗 - 现状与未来展望。
Clin Sci (Lond). 2021 Jun 11;135(11):1369-1387. doi: 10.1042/CS20210052.